InvestorsHub Logo
Followers 223
Posts 11552
Boards Moderated 1
Alias Born 07/07/2008

Re: None

Monday, 02/05/2018 11:31:27 AM

Monday, February 05, 2018 11:31:27 AM

Post# of 203908
owcp has about 5 times in o/s as does *gw--below is a post which could,eventually, imho, mean owcp could be(only my opinion) a $30pps+ stock if they do things right and their treatments develop in time... they are certainly protecting ip and patents-the marketing will follow in time: i post the following just to show the 1:5 ratio-owcp vs. *gw... we shall see-owcp is certainly in line for a jv partnership-jmho...

jcamp212 Tuesday, 01/23/18 12:14:06 PM
Re: None
Post # of 4910
Analyst Reiterates 'Buy' Rating on GW Pharma, Sees >10% Upside

SOURCE: https://www.dailymarijuanaobserver.com/single-post/2018/01/23/GWPH-Analyst-Reiterates-Buy-Rating-on-GW-Pharma-Sees-10-Percent-Upside

Leerink Swann's Paul Matteis just reiterated his 'buy' rating on shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) alongside a price target of $153.00 per share. GW Pharma currently has an average price target of $175.00 per share, and out of the four analysts we track that cover GWPH, Matteis's price target is the highest.



With a last trade price of $138.18 for shares of GW Pharma, this price target represents over 10% potential upside.